You Did What?! Controversies in Brain Tumor Management 7th Annual Northwell Health Meeting on Stereotactic Radiosurgery, Feinstein Institute for Medical Research, Friday, 14. September 2018

You Did What?! Controversies in Brain Tumor Management 7th Annual Northwell Health Meeting on Stereotactic Radiosurgery
This activity will allow participants to gain an improved fund of knowledge regarding the best practices, indications and current research pertaining to management of brain tumors with SRS.  In addition, experienced practitioners will broaden their understanding of the indications and outcomes for conditions that they may not have extensive personal experience in treating. 
Program Agenda
7:30am: Registration, Continental Breakfast and Exhibitors 
8:00am: Opening RemarksAnuj Goenka, MD and Michael Schulder, MD, FAANS
8:15am: Skull Base Tumors: To SRS or Not to SRS? That is the Question.Moderator: Michael Schulder, MD, FAANS
Eugen Hug, MD: Proton Therapy for Skull Base Tumors
Pantaleo Romanelli, MD: The Rationale of SRS for Treating Patients with Skull Based Tumors
9:30am: Debate: SRS for the Treatment of Skull Base TumorsPro: Pantaleo Romanelli, MDCon: Eugen Hug, MD
10:10am: Break
10:30am: Multiple (and we mean multiple) Brain MetastasesModerator: Anuj Goenka, MD
Arjun Sahgal, BSc, MD, FRCPC: The Rationale of SRS for Treating Multiple Brain Metastases
Kathryn Beal, MD: The Rationale of Whole Brain RT for Treating Multiple Brain Metastases and Role of Immunotherapy in CNS Disease
11:45am: Debate: Repeat SRS for Patients with Multiple Metastases is the Treatment of Choice
Pro: Arjun Sahgal, BSc, MD, FRCPCCon: Kathryn Beal, MD
12:30pm: Lunch
1:30pm: SRS for Gliomas, the Elusive TargetModerator: Alexis Demopoulos, MD
Christopher Duma, MD, FACS: Leading Edge Radiosurgery for Gliomas
Ranjit S. Bindra, MD, PhD: New Developments in RT for Gliomas
2:45pm: Debate: SRS in the Management of Gliomas
Pro: Christopher Duma, MD, FACSCon: Ranjit S. Bindra, MD, PhD
3:30pm: Closing Remarks & Adjourn
 

Statement of Need: Physicians who treat patients with conditions amenable to stereotactic radiosurgery do not always have a full understanding of the underlying principles, indications, outcomes, nuances and techniques for SRS. As there are ongoing developments in the fields of neurosurgery and radiation oncology it is difficult for clinicians to remain up-to-date. Conferences such as this aim to resolve gaps by discussing current research, breakthroughs and state-of-the-art treatment modalities. This allows patients the opportunity to take advantage of the latest, safest and most effective treatment options for their condition. As a result of this symposium, practitioners will improve their knowledge base of technical aspects, best practices, potential complications and indications of SRS to improve the clinical outcomes of patients.
Program Objectives:All Northwell Health CME activities are intended to improve patient care, safety and outcomes. At the conclusion of this conference participants should be able to
-Describe advances in SRS technology.
-Implement best practices for SRS treatment of brain tumors.
-Review indications for proton therapy and advances in the management of patients with skull base tumors.  
-Review indications for SRS treatment in patients with multiple metastases.
-Discuss the use of proton therapies for glioma.
Target Audience: Neurosurgeons, Medical and Radiation Oncologists, Neurologists, Radiologists.
CME Accreditation: Northwell Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation: Northwell Health designates this live activity for a maximum of 6.25 AMA PRA Category 1 credits ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nursing Credit: The American Nurses Credentialing Center (ANCC) will accept 1.0 AMA PRA Category 1 Credit™ as equal to 1.0 ANCC contact hour. Nurses should inquire with their specialty organizations and professional institutions as to their acceptance of AMA PRA Category 1 Credits™.
Verification of Attendance: Will be provided to all professionals.
Faculty Disclosure Policy: Northwell Health adheres to the ACCME’s Standards for Commercial Support. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with commercial interests. All relevant conflicts of interest will be resolved prior to the commencement of the activity.
Americans With Disabilities Act: This conference is in compliance with provisions of the AmericansWith Disabilities Act (ADA) and is accessible for individuals with special needs. If you would like to attend this conference and require any special needs or accommodations, please contact Jennifer Salay at (516) 719-3171.

Friday, 14. September 2018, Feinstein Institute for Medical Research, You Did What?! Controversies in Brain Tumor Management 7th Annual Northwell Health Meeting on Stereotactic Radiosurgery

Find more interesting events
Get event recommendations based on your Facebook taste. Get it now!Show me the suitable events for meNot now